SCTL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SCTL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Societal CDMO's 3-Year RORE % for the quarter that ended in Dec. 2023 was -19.75%.
The industry rank for Societal CDMO's 3-Year RORE % or its related term are showing as below:
The historical data trend for Societal CDMO's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Societal CDMO Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
3-Year RORE % | Get a 7-Day Free Trial | -24.73 | -46.05 | -23.04 | -44.20 | -19.75 |
Societal CDMO Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
3-Year RORE % | Get a 7-Day Free Trial | -44.20 | -46.75 | -34.59 | -34.88 | -19.75 |
For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Societal CDMO's 3-Year RORE % falls into.
Societal CDMO's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:
3-Year RORE % | = | ( Most Recent EPS (Diluted) | - | First Period EPS (Diluted) ) | / | ( Cumulative EPS (Diluted) for 3-year | - | Cumulative Dividends per Share for 3-year ) |
= | ( -0.15 | - | -0.31 ) | / | ( -0.81 | - | 0 ) | |
= | 0.16 | / | -0.81 | |||||
= | -19.75 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.
Societal CDMO (NAS:SCTL) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Thank you for viewing the detailed overview of Societal CDMO's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bryan M. Reasons | director | C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544 |
Elena Cant | director | C/O SOCIETAL CDMO, INC., 1 E. UWCHLAN AVENUE, SUITE 112, EXTON PA 19341 |
Enloe J David Jr | director, officer: Chief Executive Officer | |
James Charles Miller | director | 490 LAPP ROAD, MALVERN PA 19355 |
Wayne Weisman | director | 490 LAPP ROAD, MALVERN PA 19355 |
William Ashton | director | C/O HARRISON CONSULTING GROUP, PO BOX 283, NEWTOWN SQUARE PA 19073 |
Winston J Churchill | director | C/O SCP PARTNERS, SUITE 300, 1200 LIBERTY RIDGE DRIVE, WAYNE PA 19087 |
Awm Investment Company, Inc. | 10 percent owner | 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022 |
Mathew Paul Arens | director, 10 percent owner | C/O FIRST LIGHT ASSET MANAGEMENT, LLC, 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435 |
First Light Asset Management, Llc | director, 10 percent owner | 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435 |
Laura L. Parks | director | C/O RECRO PHARMA, INC., 490 LAPP ROAD, MALVERN PA 29355 |
Michael Berelowitz | director | 415 EAST 37TH STREET, APT 36C, NEW YORK NY 10016 |
Ryan David Lake | officer: Chief Financial Officer | KENSEY NASH CORPORATION, 735 PENNSYLVANIA DRIVE, EXTON PA 19341 |
Scp Vitalife Partners (israel) Ii, L.p. | 10 percent owner | SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355 |
Scp Vitalife Partners Ii Lp | 10 percent owner | SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355 |
From GuruFocus
By Marketwired • 08-23-2023
By Marketwired • 07-07-2023
By Marketwired • 10-05-2023
By sperokesalga sperokesalga • 03-03-2023
By GuruFocus Research • 08-29-2023
By Marketwired • 11-01-2023
By sperokesalga sperokesalga • 05-08-2023
By GuruFocus Research • 11-08-2023
By sperokesalga sperokesalga • 05-03-2023
By Marketwired • 09-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.